Global Healthcare Reach Envision 90TEN operates as a global healthcare communications consultancy within the Envision Pharma Group, with multiple offices across four continents. This presents an opportunity to cross-sell integrated medical affairs and patient education services to multinational pharma and biotech clients seeking consistent global messaging and local market support.

Behavioral Science Advantage The Feel-Think-Do behavioral science methodology differentiates the firm in health communications. Sales can leverage this to position offerings around patient-centric communications, adherence-focused campaigns, and evidence-driven messaging strategies to improve outcomes and brand impact for pharma clients.

Growth and Leadership Momentum Recent leadership changes and US market expansion indicate ongoing growth and renewed investment in regional capabilities. This presents a window to propose expanded service lines in digital engagement, medical education programs, and US-market regulatory communications to capture rising demand.

Part of Envision Ecosystem As part of the Envision Pharma Group, the company can be bundled with broader medical affairs, publication planning, and scientific communications services. Cross-selling to existing Envision clients could accelerate deal velocity and increase contract value.

Medium-Sized Niche Specialist With a headcount of 11-50 and revenue in the lower mid-range, Envision 90TEN sits between boutique specialist firms and large agencies. This positions it well for mid-market pharma brands seeking specialized, agile, and cost-effective healthcare communications partnerships.